US Patent 8242252 CD19 binding agents and uses thereof

Patent 8242252 was granted and assigned to Seagen on August, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Seagen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82422520

Patent Inventor Names

Hans Peter Gerber0

Paul Carter0

Charles G. Cerveny0

Charlotte McDonagh0

Dennis Benjamin0

Leigh Francisco0

Date of Patent

August 14, 2012

Patent Application Number

131099570

Date Filed

May 17, 2011

Patent Citations Received

‌

US Patent 11938194 Cysteine mutated antibodies for conjugation

Patent Primary Examiner

‌

Misook Yu

Patent abstract

This invention relates to CD 19 binding agents and methods of using such CD 19 binding agents for treating disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8242252 CD19 binding agents and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API